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Abstract Substance abuse and drug addiction are two of the
most common psychopathologies among the general popula-
tion. While a host of risk factors are associated with the onset
of drug abuse and drug addiction, there is a growing body of
evidence pointing to the powerful influence of early adverse
experiences, both child neglect and maltreatment, as well as
drug use and abuse in parents and/or primary caretakers. We
consider the case for drug addiction as a developmental dis-
order, outlining the need to consider the role of genetic, epi-
genetic, and neurobiological factors alongside experiences of
adversity at key stages of development. Such a multilevel
approach within a developmental framework has the potential
to reframe our understanding of how addiction emerges and is
maintained, and is essential if we are to identify the mecha-
nisms underlying this disorder to better inform effective treat-
ment and prevention across the generations.
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Substance abuse and drug addiction are two of the most com-
mon psychopathologies among the general population.
Across potential drugs of abuse, prevalence estimates in adult
populations for drug abuse and dependence range from 1.4 %
for 12-month to 7.7 % for lifetime drug abuse [1]. When the
behavioral addictions are also considered (e.g., gambling,
overeating), there is significant overlap in natural history, co-
morbidity, response to treatment, and etiologic mechanisms
with drug use and abuse [2]. Many addictions begin in ado-
lescence, which appears to be an especially vulnerable time
for the onset of drug use and abuse and the transition to ad-
diction [3]. There are also robust associations between the age
of onset of drug use and abuse and the severity and chronicity
of addiction [4]. While there are a host of risk factors associ-
ated with the onset of drug abuse and drug addiction, there is a
growing body of evidence pointing to the influence of early
adverse experiences, both child neglect and maltreatment, as
well as drug use and abuse in parents and/or primary care-
takers. Taken together, each of these lines of evidence suggest
that drug addiction (and perhaps addictions more generally)
may be construed as developmental disorders, that is, as dis-
orders with experiential and gene by experience antecedents
relating to early caregiving and exposure to adverse and/or
contexts characterized by deprivation.
In delineating any developmental pathway to addiction, it
is important to recognize the potential mechanisms by which
such a pathwaymay begin as early as conception.While many
women abstain from substance use during pregnancy, a sig-
nificant number continue to use substances during this time
and into the postpartum period. For those who do abstain,
relapse rates are high in the initial months following delivery
[5]. Further, substance abuse and addiction during pregnancy
are commonly associated with chronic prenatal stress in
mothers resulting in changes to maternal stress and immune
systems that may have direct effects on similar systems in the
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fetus [6]. A growing body of human research indicates the
deleterious effects of prenatal stress on birth outcomes and
postnatal development [7] especially in the domains of emo-
tion regulation that may predispose to greater risk for drug
abuse and addiction. Thus, parental substance use appears to
exert an influence on the following: (i) fetal development,
which may be reflected in increased rates of preterm delivery,
low birth weight, and multiple congenital abnormalities [8];
(ii) the prenatal environment construed more broadly as ma-
ternal health and stress management; (iii) the postpartum en-
vironment in which the infant is often in the continued care of
a substance-abusing parent; and (iv) the adversity associated
with high rates of neglect and abuse which has been reported
in substance using parents [9]. High rates of abuse and neglect
in turn expose children to chronic stress and adversity that has
been linked to increased risk for later psychopathology includ-
ing drug use.
Especially in reference to the postnatal caregiving environ-
ment, recent advances in neurobiological models of parenting
report the re-wiring of key neural circuits of stress and reward
by addiction that appear critical to supporting parenting [10•,
11•]. Indeed, for addicted parents, caring for a child is less
rewarding and more stressful owing to the dysregulation be-
tween stress and reward neural circuits. This approach pro-
vides neurobiological data to accompany observational stud-
ies that have indicated decreased engagement and increased
passivity between substance-using mothers and their newborn
infants [12]. Thus, prenatal and postnatal parental substance
use may have a detrimental effect on the developing child
early on during infancy through several pathways but espe-
cially including those relating to how parental care impacts
child stress regulatory capacities at the neural, psychobiolog-
ical, immunologic, genetic, and endocrine levels and how
those early perturbations in parental care are transmitted for-
ward to the caring behaviors of those offspring when they later
become parents themselves.
Recent data also suggest a prominent role for genetic as
well as psychosocial factors in the transmission of substance
abuse from parent to child [13, 14]. Moreover, there has been
significant progress in identifying specific genes that influ-
ence substance abuse disorders. The search for specific genes
has been aided by knowledge of developmental pathways
leading to drug abuse. For example, the central importance
of externalizing disorders in adolescence as a developmental
pathway associated with higher rates of substance use and
abuse has led to noting the importance of genes regulating
the dopamine systems for both externalizing and alcohol dis-
orders [15]. The newer techniques of genome-wide associa-
tion studies have also underscored the importance of devel-
opmental process. Of special interest has been the identifica-
tion of genes important in the earliest strategies of brain
development which are associated with substance abuse
much later on [16]. Moreover, genetic studies have been
among the best documentation of the role of social factors in
protecting or accelerating drug use. For example, the effect of
genetic factors and delinquent behavior and alcohol use in boys
are blunted in rural communities [17]. Recent comprehensive
epidemiological studies also focus on the importance of the
child’s experience of parental marriage: divorce serves as a
major risk factor for subsequent alcohol abuse and dependence
controlling for family history of substance abuse disorders [18].
The identification of endophenotypes such as impulsivity,
which are risk factors for both externalizing and substance
abuse disorders, has aided in gene identification [19]. For in-
stance, a novel adoption design suggests that the first expres-
sion of a genetic risk for addictions and related impulsive be-
havior in infants and childrenmay be problems in attention and
behavioral self-control that can be ameliorated by parents with
good emotional self-regulation who can provide appropriate
structure [20, 21]. This is consistent with data suggesting that
genetic vulnerability to substance use has been considered
through the lens of self-control and emotion regulation [22].
In particular, impulsivity has been considered a key construct
in the emergence of substance dependence during adolescence
[23], with increasing levels of impulsivity and risky behavior
more generally being higher during this developmental period.
Notably, adolescence is marked by higher rates of experimen-
tal drug use, and substance use disorders begin to emerge [3,
24], an observation underscoring the importance of this period
in the pathway to addiction before individuals even enter adult-
hood. Parents play a critical role in the socialization and regu-
lation of emotions and behaviors in children, and children also
shape and contribute to their parent’s own behavior regulatory
functioning (e.g., [25, 26]). Indeed, families have their own
capacities for self-regulation that may provide a protective ef-
fect against the transmission of substance abuse across gener-
ations [27]. Further, programs that focus on early parent-child
relationships and closely related social processes have shown
efficacy in preventing substance abuse (e.g. [28, 29]).
In sum, a growing body of research suggests a continuous
set of circumstances from the intrauterine periods though in-
fancy, childhood, and early adolescence through which indi-
viduals follow increasingly clear developmental pathways to-
wards serious addictive disorders. The papers in this special
issue each contribute distinct lines of evidence addressing the
reframing of addictions as developmental disorders, focussing
specifically on the following: (a) the role of gene-environment
interactions in the emergence of specific addictive disorders;
(b) the role of epigenetic mechanisms; (c) the role of early
adversity in changing brain systems relevant to an addictive
process; (d) the role of emotion regulation difficulties in key
developmental periods such as adolescence in addiction and
other psychopathologies; and (e) the use of developmentally
and mechanism-informed intervention/prevention programs
to reduce the risk for drug use and abuse across the develop-
mental life span.
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Milaniak,Watson, and Jaffee examine candidate gene studies
that test gene × environment interactions with a focus on vari-
ants consistently associated with substance use and abuse. They
specifically review the genes associated with nicotine, cannabis,
and alcohol use and abuse with special attention to the genes
linked to neural systems involved in addiction. What emerges is
a mixed though provocative set of findings from quantitative
behavioral genetic studies regarding gene × environment inter-
actions in candidate gene studies. Importantly, while small, un-
derpowered studies are surely problematic, the authors point to
the challenge of obtaining adequately fine-grained measures of
environmental factors in larger samples. Further, they under-
score the need to guide genetic studies by biologically plausible
mechanisms for drug use and abuse and for a more mechanisti-
cally informed understanding of environmental variables (e.g.,
more proximal measures of parental care behavior, the caring
environment, or the impact of peer to peer interactions). Getting
closer to developmental mechanisms also requires more transla-
tional research bringing together human and animal studies.
Cecil, Walton, and Viding address the role of epigenetic
mechanisms in the onset of substance use disorders with a
particular focus on DNA methylation. Across both human
and animal studies, evidence generally supports an association
with DNA methylation and substance use/addiction with the
suggestion that developmental timing is key. The authors
point to the limited knowledge today on the normal patterns
in the methylome especially in humans and the variation by
tissue, cell-type, gender, and age as well as the relative contri-
bution of genetic and environmental influences on observed
methylation patterns and a paucity of longitudinal studies be-
ginning early with repeated assessments of methylation. That
said, the authors report promising lines of evidence indicating
that prenatal alcohol exposure is associated with increased
methylation and decreased expression of a gene implicated
in stress response, metabolism, and immune function. Such
a finding provides one putative mechanism through which
fetal programming can occur with prenatal alcohol exposure
contributing to HPA axis dysregulation and increased addic-
tion risk in adolescence and adulthood. While providing some
preliminary clues regarding potential developmental mecha-
nisms, epigenetic studies of addictive disorders are in their
infancy and Cecil and colleagues make a compelling argu-
ment for a much more systematic study of the relationship
between DNA methylation and addiction across tissues, sub-
stances, and developmental periods. The need for more longi-
tudinal designs within human studies is clearly essential if we
are to move from isolated findings regarding the role of
DNAm in the pathophysiology of addiction to using such data
as disease biomarkers that may inform therapeutic targets.
Puetz and McCrory examine the impact of early child mal-
treatment on key neural systems implicated in addictionmech-
anisms, namely reward processing, decision-making, and af-
fect regulation. Early childhood adversity is associated with
increased risk for a range of comorbid psychiatric disorders
including substance use and addiction, and a growing body of
work has demonstrated that childhood maltreatment is associ-
ated with functional and structural changes in these same sys-
tems. Adults presenting with addictive disorders show chang-
es in these systems including heightened striatal response to
salient stimuli and dampened fronto-cingulate regulation.
Puetz andMcCrory draw parallels with the remarkably similar
pattern of findings in maltreated children and suggest that
these early neurodevelopmental changes may in part account
for the especially severe and chronic addiction profiles in
adults with early histories of maltreatment. Specifically, they
argue that early changes in brain structure and function fol-
lowing exposure to childhood maltreatment may instantiate
increased latent vulnerability to addictive behavior in adoles-
cence and adulthood [30•]. Alterations in neural systems in-
volved in reward processing, decision-making, and affect reg-
ulation may have a proximal adaptive value early in develop-
ment, but alterations may also incur long-term costs, increas-
ing the risk for later psychopathology, including addiction.
With a perspective complementary to Puetz and McCrory,
Shadur and Lejuez further explore developmental mechanisms
by examining the relationship between emotional regulation in
adolescence and risk for substance use and addiction. They high-
light the need for understanding risk factors that cut across diag-
noses and conditions, which may contribute to risk embedded
across development. They cite emotion regulation deficits as a
core transdiagnostic risk factor underlying the development of
substance use, addiction, and comorbid psychopathology in ad-
olescence. The dual-systemsmodel of neurological development
highlights adolescence as a critical period for increased risk for
emotion regulation difficulties. In this model, the cognitive con-
trol system including prefrontal and parietal regions and the an-
terior cingulate is crucial to decision-making but is functionally
dominated by a second affective system that includes regions
which are important to processing reward and social and emo-
tional salience, including but not limited to the amygdala, ventral
striatum, orbitofrontal cortex, medial prefrontal cortex, and the
superior temporal sulcus. The dominance of the affective system
contributes to heightened reward sensitivity and a reward-
seeking behavior, a crucial factor biasing decision-making and
contributing to increased experimentation with drugs and the
emergence of substance use/abuse. Shadur and Lejuez use two
established developmental theories linked to emerging substance
use disorders, the externalizing pathway and the internalizing
pathway, which together highlight how early embedded risk in
the form of emotion regulation deficits accounts for the develop-
ment of addiction and comorbid psychiatric disorders. They also
point to the implications for intervention, especially with adoles-
cents, arguing for the particular need of addressing contextual
stressors in higher risk developmental periods.
Finally, Fisher and Berkman continue the theme of
mechanism-informed interventions by focusing on the
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transgenerational effects on the development of addictive disor-
ders through interventions directly addressing the effects of early
adversity. They make the argument that prevention efforts in-
formed by the science of early adversity and chronic stress may
reduce the population-level incidence of addictions. They pro-
pose an innovative framework for how translational neurosci-
ence that is focused on the effects of early adversity may inform
addictions intervention, describing an application of their pro-
posed model in relation to smoking cessation. They argue that
because of the common neural pathways of addiction, similar
approaches to the one they illustrate for smoking cessation may
prove applicable to other drug as well as behavioral addictions.
Taken together, these five papers begin to provide a compel-
ling though incomplete case for addiction as a developmental
disorder; however, much more longitudinal research is required
with greater transdisciplinary and translational emphasis. Never-
theless, each of these papers offers a perspective on a develop-
mental research agenda for a potentiallymore fruitful approach to
understanding the mechanisms of addictions and their effective
treatment and prevention across two and three generations.
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